Newer oral anticoagulants reduce event risk in AF, GI bleeding vs. warfarin

Non-vitamin K antagonist oral anticoagulants conferred lower risk for ischemic stroke and major bleeding in patients with atrial fibrillation and a history of gastrointestinal bleeding compared with warfarin, according to study results.“Oral anticoagulant therapy is essential for the prevention of thromboembolic events in patients with AF. The introduction of non-vitamin K antagonist oral anticoagulants has facilitated uptake of thromboprophylaxis,” Soonil Kwon, MD, from Seoul National University Hospital in South Korea, and colleagues wrote. “However, the effectiveness andRead More